SCHEMBL29983070

SCHEMBL29983070

COc1cc(-c2nccc(-c3cccc(NC(=O)c4ccc(CNC[C@@H](C)O)cn4)c3C)c2Cl)ccc1CNC[C@@H](C)O

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 20/20 0.56
▸ CD274 Q9NZQ7 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29982055 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL27078714 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL27079858 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL27079821 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL27079123 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL29983308 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL27078707 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL29981986 1.00 PDCD1 (0.56) PDCD1CD274
SCHEMBL29982671 0.95 PDCD1 (0.49) PDCD1CD274
SCHEMBL29983137 0.95 PDCD1 (0.49) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313968-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2024-02-07 — — EP claimed
WO-2022208269-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-10-06 — — WO claimed
EP-4313968-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2024-02-07 — — EP disclosed
WO-2022208269-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-10-06 — — WO disclosed
Send feedback